spacer
home > epc > winter 2018 > smooth sailing
PUBLICATIONS
European Pharmaceutical Contractor

Smooth Sailing

Clinical trials are performed to accumulate the required information about safety and efficacy of new medicinal products including small and large molecules or medical devices. Before those products hit the healthcare market – if at all – the authorisation procedure passes through numerous steps and stages. In this process, the analysis of clinical samples represents only a minor, but important, portion. Next to safety laboratory testing (which is mandatory in monitoring a new drug), results of lab analyses also provide important evidence on the mode of action of the new medicinal product in vivo.

Pharmacokinetic (PK) tests reveal the buildup of the plasma level of the drug and its successive metabolism and excretion over time. Pharmacodynamic (PD) analyses shed a light on the mode of action of the substance in the human body. More biomarker molecules are being described as an indicator for various physiological conditions. Hence, with each measurement, the researchers gain essential insight into biological processes within the human body.

Subcontracting a Central Lab


For a number of years already, clinical studies have had a tendency to become more complex, consequently leading to challenging analytical demands. Therefore, in multinational trials, many sponsors decide to subcontract one central lab provider instead of many local labs, which results in a broader service portfolio as well as a more efficient sample management and readily comparable lab data.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Sarah Waelde is Manager Business Development at SYNLAB pharma institute – a leading provider of central lab and advanced diagnostic services for the pharma industry, performing general strategic and tactical account-planning next to managing customer relationships. Her expertise in the pharma sector derives from several years of extensive sales. Sarah holds a degree in biology and spent three years as a Postdoctoral Researcher at the YALE School of Medicine, US, investigating the activation of mitotic entry in fission yeast.

Dr Holger Schoeneborn
has more than 15 years of experience in the pharma industry. After 11 years in project management and involvement in more than 100 clinical trials, he is now heading the sample management department and scientific support at SYNLAB pharma institute in Munich. Holger holds a PhD degree in biology from the Technical University Munich, Germany.

spacer
Dr Sarah Waelde
spacer
spacer
spacer
Dr Holger Schoeneborn
spacer
spacer
Print this page
Send to a friend
Privacy statement

White Papers

Recommendations for Implementing Assessment Criteria Guidelines in Lymphoma and Chronic Lymphocytic Leukemia Clinical Trials

Perceptive Informatics

Standardized assessment criteria are becoming increasingly important in obtaining valid outcomes in oncology clinical trials. While standardized criteria encourage a more uniform approach to assessing clinical trial data, they are often subject to the interpretation of the user. These differences in interpretation, while seemingly minor, can have a major impact on assessments. The most commonly used standardized criteria for lymphoma have been no exception. Differences such as minimum new lesion size, lymph node normalization size requirements, inclusion of extranodal lesions and assessment of organomegaly can have a profound effect on overall response. Additionally, heightened scrutiny of the assessment criteria used in a given protocol can lead to questions about a drug’s efficacy if not applied correctly according to regulators’ interpretation.
More info >>

 
Industry Events

LogiPharma 2019

9-11 April 2019, Montreux Music & Convention Centre

LogiPharma is the world’s leading pharma supply chain event. With over 950+ pharma supply chain leaders exclusively meeting in one place at one time, LogiPharma is THE meeting place to benchmark your business with the best pharma companies and shape the future of your industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement